AzTrials
AzTrials

Endotracheal IntubationNCT02395419

A Comparison of Tracheal Intubation Using the Totaltrack vs the Airtraq Laryngoscope in Routine Airway Management

A study testing Orotracheal intubation with Totaltrack and Orotracheal intubation with Airtraq in people with Endotracheal Intubation, run by Manuel Ángel Gómez-Ríos at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Endotracheal intubation is usually required to allow unrestricted surgical approach. The Macintosh laryngoscope is the standard method. However in certain situations as difficult airway this technique is ineffective and poorly tolerated by the patient. Read more about this study

Who is it for?
Ages 18 to 100 years
Conditions the study is for
Endotracheal Intubation
What is being tested?
Orotracheal intubation with Totaltrack and Orotracheal intubation with Airtraq
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
48 participants
Where
1 siteSpain
Study dates
Oct 2016to Nov 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients undergoing elective general anesthesia requiring OTI.
  • Patients duly informed and they have signed the informed consent during the pre-anesthetic consultation, or be sought after due meditation, expressing its consent to the inclusion in the study.
  • Age ≥18 years.
  • ASA I-III.
  • Sufficient intellectual capacity to understand the procedure and equipment used.
  • Do not submit predictors of difficult airway (Mallampati class III or IV; thyromental distance <6 cm, sternomental distance <12.5 cm, interincisal distance<4.0 cm, bite test II or III, cervical mobility <90 ° or history of difficult intubation).
Show all 11Show fewer
  • Do not undergo thyroid surgery or present pharyngolaryngeal, glottic or cervical pathology
  • BMI <30kg / m2
  • Not presenting risk factors for aspiration
  • Not presenting respiratory disease, coronary or cerebral vascular.
  • Do not have a sore throat preoperative

Who cannot join

  • Failure to meet the above criteria
  • Pregnancy
  • Allergy to any drug included in the protocol.

Trial locations and contacts

1 site in 1 country.

Manuel G Gómez-Ríos, MD contact

+34636909413

magoris@hotmail.com

Spain1 site, 1 recruiting
  • Manuel Gómez Ríos

    A Coruña, A Coruña, 15006

    Manuel Á Gómez-Ríos, +34636909413, magoris@hotmail.com

    Recruiting

Other trials in Spain

About this study

Endotracheal intubation is usually required to allow unrestricted surgical approach. The Macintosh laryngoscope is the standard method. However in certain situations as difficult airway this technique is ineffective and poorly tolerated by the patient. Fiberoptic intubation is the gold standard in this scenario, however sometimes it is not possible due to failure or unavailability, so alternatives are needed. The TotalTrack (MedComflow SA, Barcelona, Spain) and the Airtraq (Prodol Meditec, Vizcaya, España) been designed specifically for the airway management. However, despite their use in clinical practice, there are no comparative studies.

Being tested
Orotracheal intubation with Totaltrack, Orotracheal intubation with Airtraq

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Orotracheal intubation with TotaltrackDevice

  • Orotracheal intubation with AirtraqDevice

Study groups in NCT02395419
Study groupRoleWhat they receive
TotaltrackActive comparatorOTI with TotalTrack
Receives: Device: Orotracheal intubation with Totaltrack
AirtraqActive comparatorOTI with Airtraq
Receives: Device: Orotracheal intubation with Airtraq

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Total time of successful intubation

    Measured: Time of Orotracheal intubation (TOTI)

Secondary outcomes (10)
  1. difficulty in intubation (IDS scale)

    Measured: TOTI

  2. percentage of glottic opening (POGO Score)

    Measured: TOTI

  3. number of maneuvers

    Measured: TOTI

  4. Number of attempts of endotracheal intubation

    Measured: TOTI

  5. Position taken by the anesthesiologist during orotracheal intubation

    Measured: TOTI

  6. hemodinamic response

    heart ratio, arterial pressure

    Measured: OTI pre and postintubation (time minutes)

  7. Complications

    Measured: OTI and postintubation (24 hours)

  8. endotracheal intubation success rate of each device

    Measured: TOTI

  9. Degree of satisfaction

    Visual Analogic Scale

    Measured: time of postintubation (ten minutes)

  10. hemodinamic response

    arterial pressure

    Measured: OTI pre and postintubation (time minutes)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Mar 2015 (estimated)
  2. Study startOct 2016
  3. Primary completionNov 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
48 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02395419
Sponsor's protocol ID
MGR-TAT-2015-F1
Status last verified
Oct 2016
First submitted
10 Mar 2015
Last updated
17 Oct 2016
Results posted
No
Data monitoring committee
No

Publications

  • Pearce A. Evaluation of the airway and preparation for difficulty. Best Pract Res Clin Anaesthesiol. 2005 Dec;19(4):559-79. doi: 10.1016/j.bpa.2005.07.004.

    PubMed 16408534
  • Adnet F, Borron SW, Racine SX, Clemessy JL, Fournier JL, Plaisance P, Lapandry C. The intubation difficulty scale (IDS): proposal and evaluation of a new score characterizing the complexity of endotracheal intubation. Anesthesiology. 1997 Dec;87(6):1290-7. doi: 10.1097/00000542-199712000-00005.

    PubMed 9416711
  • Ochroch EA, Hollander JE, Kush S, Shofer FS, Levitan RM. Assessment of laryngeal view: percentage of glottic opening score vs Cormack and Lehane grading. Can J Anaesth. 1999 Oct;46(10):987-90. doi: 10.1007/BF03013137.

    PubMed 10522589

Questions about this trial

What is this clinical trial studying?

A study testing Orotracheal intubation with Totaltrack and Orotracheal intubation with Airtraq in people with Endotracheal Intubation, run by Manuel Ángel Gómez-Ríos at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 Oct 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Manuel G Gómez-Ríos, MD (+34636909413, magoris@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Total time of successful intubation (time frame: Time of Orotracheal intubation (TOTI)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02395419, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Oct 2016; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in